3.4.21.B12: prostase
This is an abbreviated version!
For detailed information about prostase, go to the full flat file.
Word Map on EC 3.4.21.B12
-
3.4.21.B12
-
klk4
-
kallikreins
-
amelogenins
-
amelogenesis
-
ameloblastin
-
enamelysin
-
incisor
-
imperfecta
-
maturation-stage
-
amelx
-
amelotin
-
medicine
-
secretory-stage
-
hypomineralized
-
masp-1
-
hypomaturation
-
crystallite
-
metalloproteinase-20
-
analysis
-
diagnostics
- 3.4.21.B12
- klk4
- kallikreins
- amelogenins
-
amelogenesis
- ameloblastin
- enamelysin
- incisor
- imperfecta
-
maturation-stage
-
amelx
-
amelotin
- medicine
-
secretory-stage
-
hypomineralized
- masp-1
-
hypomaturation
-
crystallite
-
metalloproteinase-20
- analysis
- diagnostics
Reaction
proteolysis of polypeptides =
Synonyms
EM serine proteinase 1, EMSP1, enamel matrix serine protease 1, HK4, K4, kallikrein 1-related peptidase 4, kallikrein 4, kallikrein-4, kallikrein-4 proteinase, kallikrein-like protein 1, kallikrein-related peptidase, kallikrein-related peptidase 4, kallikrein-related peptidase-4, KLK, KLK-4 proteinase, KLK-L1, KLK4, More, peptidase S01.251, prostase, prostate cancer serine protease, PRSS17, S01.251, serine protease 1, serine protease 17, tissue kallikrein-related peptidase 4
ECTree
Advanced search results
Inhibitors
Inhibitors on EC 3.4.21.B12 - prostase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
MCoTI-II
a 34-amino acid cyclic peptide found in the seeds of Momordica cochinchinensis. By grafting a preferred KLK4 cleavage sequence into MCoTI-II, a highly potent KLK4 inhibitor is produced that displays 100000fold selectivity over related kallikreins and the ability to penetrate cells. Additionally, by substituting positively charged noncontact residues in this compound, a potent and selective KLK4 inhibitor is produced that does not penetrate cells. The inhibitors are shown to be nontoxic to human cells and stable in human serum. These KLK4 inhibitors provide useful chemical tools to further define the role(s) of both intracellular and extracellular KLK4 in prostate cancer cell lines and disease models
-
siRNA
-
mediates knockdown of endogenous KLK4 in LNCaP prostate cancer cells whereby inhibiting their proliferation
-
Zn2+
-
enzyme activity is high at zinc concentrations below 0.001 mM and decreases to about 30% at 0.1 mM. Zinc affects the K4 active site via the salt-bridge formed between the N terminus and Asp194 required for a functional active site
-
complex formation with the self-activated recombinant, chimeric enzyme
inhibition of KLK4 expression results in diminished invasive potential in OSCC cell lines
-
additional information
-
inhibition of KLK4 expression results in diminished invasive potential in OSCC cell lines
-